836 research outputs found
Discovery Radiomics via Deep Multi-Column Radiomic Sequencers for Skin Cancer Detection
While skin cancer is the most diagnosed form of cancer in men and women, with
more cases diagnosed each year than all other cancers combined, sufficiently
early diagnosis results in very good prognosis and as such makes early
detection crucial. While radiomics have shown considerable promise as a
powerful diagnostic tool for significantly improving oncological diagnostic
accuracy and efficiency, current radiomics-driven methods have largely rely on
pre-defined, hand-crafted quantitative features, which can greatly limit the
ability to fully characterize unique cancer phenotype that distinguish it from
healthy tissue. Recently, the notion of discovery radiomics was introduced,
where a large amount of custom, quantitative radiomic features are directly
discovered from the wealth of readily available medical imaging data. In this
study, we present a novel discovery radiomics framework for skin cancer
detection, where we leverage novel deep multi-column radiomic sequencers for
high-throughput discovery and extraction of a large amount of custom radiomic
features tailored for characterizing unique skin cancer tissue phenotype. The
discovered radiomic sequencer was tested against 9,152 biopsy-proven clinical
images comprising of different skin cancers such as melanoma and basal cell
carcinoma, and demonstrated sensitivity and specificity of 91% and 75%,
respectively, thus achieving dermatologist-level performance and \break hence
can be a powerful tool for assisting general practitioners and dermatologists
alike in improving the efficiency, consistency, and accuracy of skin cancer
diagnosis
Highly accurate model for prediction of lung nodule malignancy with CT scans
Computed tomography (CT) examinations are commonly used to predict lung
nodule malignancy in patients, which are shown to improve noninvasive early
diagnosis of lung cancer. It remains challenging for computational approaches
to achieve performance comparable to experienced radiologists. Here we present
NoduleX, a systematic approach to predict lung nodule malignancy from CT data,
based on deep learning convolutional neural networks (CNN). For training and
validation, we analyze >1000 lung nodules in images from the LIDC/IDRI cohort.
All nodules were identified and classified by four experienced thoracic
radiologists who participated in the LIDC project. NoduleX achieves high
accuracy for nodule malignancy classification, with an AUC of ~0.99. This is
commensurate with the analysis of the dataset by experienced radiologists. Our
approach, NoduleX, provides an effective framework for highly accurate nodule
malignancy prediction with the model trained on a large patient population. Our
results are replicable with software available at
http://bioinformatics.astate.edu/NoduleX
Recommended from our members
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis.
Radiomics is an emerging technology for imaging biomarker discovery and disease-specific personalized treatment management. This paper aims to determine the benefit of using multi-modality radiomics data from PET and MR images in the characterization breast cancer phenotype and prognosis. Eighty-four features were extracted from PET and MR images of 113 breast cancer patients. Unsupervised clustering based on PET and MRI radiomic features created three subgroups. These derived subgroups were statistically significantly associated with tumor grade (p = 2.0 × 10-6), tumor overall stage (p = 0.037), breast cancer subtypes (p = 0.0085), and disease recurrence status (p = 0.0053). The PET-derived first-order statistics and gray level co-occurrence matrix (GLCM) textural features were discriminative of breast cancer tumor grade, which was confirmed by the results of L2-regularization logistic regression (with repeated nested cross-validation) with an estimated area under the receiver operating characteristic curve (AUC) of 0.76 (95% confidence interval (CI) = [0.62, 0.83]). The results of ElasticNet logistic regression indicated that PET and MR radiomics distinguished recurrence-free survival, with a mean AUC of 0.75 (95% CI = [0.62, 0.88]) and 0.68 (95% CI = [0.58, 0.81]) for 1 and 2 years, respectively. The MRI-derived GLCM inverse difference moment normalized (IDMN) and the PET-derived GLCM cluster prominence were among the key features in the predictive models for recurrence-free survival. In conclusion, radiomic features from PET and MR images could be helpful in deciphering breast cancer phenotypes and may have potential as imaging biomarkers for prediction of breast cancer recurrence-free survival
Recommended from our members
Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer.
Routine follow-up visits and radiographic imaging are required for outcome evaluation and tumor recurrence monitoring. Yet more personalized surveillance is required in order to sufficiently address the nature of heterogeneity in nonsmall cell lung cancer and possible recurrences upon completion of treatment. Radiomics, an emerging noninvasive technology using medical imaging analysis and data mining methodology, has been adopted to the area of cancer diagnostics in recent years. Its potential application in response assessment for cancer treatment has also drawn considerable attention. Radiomics seeks to extract a large amount of valuable information from patients' medical images (both pretreatment and follow-up images) and quantitatively correlate image features with diagnostic and therapeutic outcomes. Radiomics relies on computers to identify and analyze vast amounts of quantitative image features that were previously overlooked, unmanageable, or failed to be identified (and recorded) by human eyes. The research area has been focusing on the predictive accuracy of pretreatment features for outcome and response and the early discovery of signs of tumor response, recurrence, distant metastasis, radiation-induced lung injury, death, and other outcomes, respectively. This review summarized the application of radiomics in response assessments in radiotherapy and chemotherapy for non-small cell lung cancer, including image acquisition/reconstruction, region of interest definition/segmentation, feature extraction, and feature selection and classification. The literature search for references of this article includes PubMed peer-reviewed publications over the last 10 years on the topics of radiomics, textural features, radiotherapy, chemotherapy, lung cancer, and response assessment. Summary tables of radiomics in response assessment and treatment outcome prediction in radiation oncology have been developed based on the comprehensive review of the literature
- …